evokepharma.com - היקף יתרות המזומנים של החברה EVOK

סמלים רשמיים של חברת Evoke Pharma (EVOK)

Evoke Pharma, Inc. (EVOK) is promoting a niche gastrointestinal drug whose liquidity depends on insurance reimbursements. However, marketing expenses currently exceed revenue, depleting capital. The development of nasal sprays for diabetics and partnerships with US hospitals mitigate risks. Cash and cash equivalents help assess the company's stability, and the value of 0.01 captures this metric.

EVOK - היקף יתרות המזומנים של החברה Evoke Pharma, Inc בטווח 04.07.2022 - 27.12.2025

פילוחי מדדים ואנליטיקה של חברת Evoke Pharma (EVOK)

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח מקיף של החברה:Evoke Pharma, Inc. EVOK
מוצר ממותג של evokepharma.com

Evoke Pharma, Inc. (EVOK) outsources the production of nasal sprays to a third-party contractor, which necessitates continuous funding of reserve capacities. This indicator measures the total volume of liquid assets available to cover operating expenses and unforeseen liabilities. The investor analyzes payment dynamics to determine the actual autonomy of the business. A decrease in the cash balance signals a risk of capital deficiency. A stable plateau on the chart confirms the issuer's financial stability.